This inventor holds 2 USPTO granted patents. Top assignees: Harvard College, The Board Institute, Inc., The Broad Institute, Inc.. Active years: 2015-2018.
Company Filing History:
2 out of 3,071 
1 out of 7 
1 out of 482 
Years Active: 2015-2018
Title: Innovations by Matthias Leiendecker
Introduction
Matthias Leiendecker is a notable inventor based in Trier, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of isocitrate dehydrogenase related diseases. With a total of two patents to his name, his work reflects a commitment to advancing medical science.
Latest Patents
Leiendecker's latest patents focus on compounds and methods for the treatment of isocitrate dehydrogenase related diseases. The inventions relate to compounds of Formula I or a pharmaceutically acceptable salt, ester, or prodrug thereof. These innovations aim to provide new therapeutic options for patients suffering from these conditions.
Career Highlights
Throughout his career, Matthias has worked with prestigious institutions such as Harvard College and The Board Institute, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Mahmud Hussain and Daisuke Ito. Their collaborative efforts have further enhanced the impact of Leiendecker's inventions in the medical community.
Conclusion
Matthias Leiendecker's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare. His work continues to inspire future advancements in the treatment of isocitrate dehydrogenase related diseases.